ESR1 and ovarian carcinoma: Type 1, or low grade ovarian carcinoma, arises from low malignant potential tumors, and harbor a higher frequency of Ras and Raf mutations (approximately 60%, with one study identifying 30% mutation rates in either gene respectively [4], [46]), as well as a high percent of ERα expression (approximately 60–80%) [47].